These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 23528736)
1. Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system. Lee MJ; Lee JH; Rubinsztein DC Prog Neurobiol; 2013 Jun; 105():49-59. PubMed ID: 23528736 [TBL] [Abstract][Full Text] [Related]
2. The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease. Zhang Y; Chen X; Zhao Y; Ponnusamy M; Liu Y Rev Neurosci; 2017 Nov; 28(8):861-868. PubMed ID: 28704199 [TBL] [Abstract][Full Text] [Related]
3. The Ubiquitin System in Alzheimer's Disease. Harris LD; Jasem S; Licchesi JDF Adv Exp Med Biol; 2020; 1233():195-221. PubMed ID: 32274758 [TBL] [Abstract][Full Text] [Related]
4. Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease. Weng FL; He L Neurobiol Aging; 2021 Mar; 99():79-85. PubMed ID: 33422896 [TBL] [Abstract][Full Text] [Related]
5. Degradation of tau protein by autophagy and proteasomal pathways. Wang Y; Mandelkow E Biochem Soc Trans; 2012 Aug; 40(4):644-52. PubMed ID: 22817709 [TBL] [Abstract][Full Text] [Related]
6. Tau Clearance Mechanisms. Tang M; Harrison J; Deaton CA; Johnson GVW Adv Exp Med Biol; 2019; 1184():57-68. PubMed ID: 32096028 [TBL] [Abstract][Full Text] [Related]
7. UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation. Subramanian M; Hyeon SJ; Das T; Suh YS; Kim YK; Lee JS; Song EJ; Ryu H; Yu K Nat Commun; 2021 Jun; 12(1):3291. PubMed ID: 34078905 [TBL] [Abstract][Full Text] [Related]
9. Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis. Cao J; Zhong MB; Toro CA; Zhang L; Cai D Neurosci Lett; 2019 Jun; 703():68-78. PubMed ID: 30890471 [TBL] [Abstract][Full Text] [Related]
10. The ubiquitin-proteasome system in Alzheimer's disease. Oddo S J Cell Mol Med; 2008 Apr; 12(2):363-73. PubMed ID: 18266959 [TBL] [Abstract][Full Text] [Related]
11. Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system. van Leeuwen FW; Hol EM; Fischer DF J Alzheimers Dis; 2006; 9(3 Suppl):319-25. PubMed ID: 16914870 [TBL] [Abstract][Full Text] [Related]
12. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Ciechanover A; Kwon YT Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616 [TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer's Disease. Zhao Y; Zhang Y; Zhang J; Zhang X; Yang G Curr Neuropharmacol; 2020; 18(8):720-739. PubMed ID: 31934838 [TBL] [Abstract][Full Text] [Related]
14. Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities. Schmidt MF; Gan ZY; Komander D; Dewson G Cell Death Differ; 2021 Feb; 28(2):570-590. PubMed ID: 33414510 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. Korolchuk VI; Menzies FM; Rubinsztein DC FEBS Lett; 2010 Apr; 584(7):1393-8. PubMed ID: 20040365 [TBL] [Abstract][Full Text] [Related]
16. Rab21 Protein Is Degraded by Both the Ubiquitin-Proteasome Pathway and the Autophagy-Lysosome Pathway. Liu P; Wu A; Li H; Zhang J; Ni J; Quan Z; Qing H Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163051 [TBL] [Abstract][Full Text] [Related]
17. Dysfunction of different cellular degradation pathways contributes to specific β-amyloid42-induced pathologies. Ji XR; Cheng KC; Chen YR; Lin TY; Cheung CHA; Wu CL; Chiang HC FASEB J; 2018 Mar; 32(3):1375-1387. PubMed ID: 29127191 [TBL] [Abstract][Full Text] [Related]
18. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system. de Vrij FM; Fischer DF; van Leeuwen FW; Hol EM Prog Neurobiol; 2004 Dec; 74(5):249-70. PubMed ID: 15582222 [TBL] [Abstract][Full Text] [Related]
19. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease? Matsuda N; Tanaka K J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621 [TBL] [Abstract][Full Text] [Related]
20. The Dynamics and Turnover of Tau Aggregates in Cultured Cells: INSIGHTS INTO THERAPIES FOR TAUOPATHIES. Guo JL; Buist A; Soares A; Callaerts K; Calafate S; Stevenaert F; Daniels JP; Zoll BE; Crowe A; Brunden KR; Moechars D; Lee VM J Biol Chem; 2016 Jun; 291(25):13175-93. PubMed ID: 27129267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]